The Weekly Recap 5/2/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni secure over $35M in new funding, receive FDA 510(k) clearance, expand product lines, and much more on the road to LSI Asia ‘25 in Singapore (June 10-13). This blog is originally published here: https://shorturl.at/snhqc

Predictable Winners: How to Improve the Odds of Success in Medtech Innovation

Most innovations fail. And most companies struggle with innovation. Case in point: Nearly all the growth in the S&P 500 (prior to 2025 YTD) has been driven by just seven companies, the so-called “Magnificent Seven”—Alphabet, Amazon, Apple, Meta, Microsoft, NVIDIA, and Tesla. Between 2013 and 2019, they delivered 19% compound returns. This blog is originally published here: https://shorturl.at/8HgKw

The Memo: Medulla Pro Guiding the Next Generation of Needle-Based Procedures

Under the direction of CEO Boyle Suwono, Medulla Pro is reimagining how clinicians perform some of the most common—but error-prone—procedures in medicine. From lumbar punctures to nerve blocks, the company is building intuitive, real-time ultrasound guidance systems designed to boost precision, improve outcomes, and reduce procedural complications for patients and providers alike. This blog is originally published here: https://shorturl.at/VWZ1d

New Era — Build to Buys | LSI USA '25

Industry leaders from Baxter International and top medtech innovators join moderator Joe Mullings to discuss the strategic shift toward "Build to Buy" models shaping the future of healthcare investments and acquisitions. For more information visit https://shorturl.at/Pes4n

Transatlantic Investing and Fund II Strategy, with Panakes Partners

Diana brings 23 years of venture capital experience and previously co-founded another successful venture capital firm called 360 Capital. Alessio, with an engineering background, co-founded Panakes in 2015 after working as a research engineer at Sofinnova Partners. Throughout the episode, Diana and Alessio provide valuable insights into the evolving landscape of medtech investing, shedding light on the complexities, challenges, and opportunities in the field. For more information visit here: https://shorturl.at/TNMk1